Evidence map›Paper›PMID 24800238›Full record

ArticleBioMed research international2014

Cytokines, fatigue, and cutaneous erythema in early stage breast cancer patients receiving adjuvant radiation therapy.

Vitaliana De Sanctis, Linda Agolli, Vincenzo Visco, Flavia Monaco, Roberta Muni, Alessandra Spagnoli, Barbara Campanella, Maurizio Valeriani, Giuseppe Minniti, Mattia F Osti and 8 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results.International journal of radiation oncology, biology, physics · 2020
    Trial
  2. Trial
  3. Article
  4. Article
  5. The Skin-Brain Axis: From UV and Pigmentation to Behaviour Modulation.International journal of molecular sciences · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Vitaliana De SanctisDepartment of Translational Medicine, Institute of Radiation Oncology, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.
Linda AgolliDepartment of Translational Medicine, Institute of Radiation Oncology, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.ORCID 0000-0003-1534-4386
Vincenzo ViscoDepartment of Clinical and Molecular Medicine, Cellular Diagnostic Unit, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.
Flavia MonacoDepartment of Translational Medicine, Institute of Radiation Oncology, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.ORCID 0000-0002-2241-0460
Roberta MuniDepartment of Translational Medicine, Institute of Radiation Oncology, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.
Alessandra SpagnoliStatistics, Probability and Applied Statistics, "Sapienza" University, Piazzale Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0002-7772-3130
Barbara CampanellaDepartment of Translational Medicine, Institute of Radiation Oncology, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.
Maurizio ValerianiDepartment of Translational Medicine, Institute of Radiation Oncology, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.
Giuseppe MinnitiDepartment of Translational Medicine, Institute of Radiation Oncology, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.
Mattia F OstiDepartment of Translational Medicine, Institute of Radiation Oncology, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.
Claudio AmantiDepartment of Translational Medicine, Breast Surgery, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.
Patrizia PellegriniDepartment of Clinical and Molecular Medicine, Medical Oncology, "Sapienza" University and IDI-IRCCS, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.
Serena BrunettiUOD Psyco-oncology, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.
Anna CostantiniUOD Psyco-oncology, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.
Marco AlfòStatistics, Probability and Applied Statistics, "Sapienza" University, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Maria Rosaria TorrisiDepartment of Clinical and Molecular Medicine, Cellular Diagnostic Unit, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.
Paolo MarchettiDepartment of Clinical and Molecular Medicine, Medical Oncology, "Sapienza" University and IDI-IRCCS, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.
Riccardo Maurizi EnriciDepartment of Translational Medicine, Institute of Radiation Oncology, "Sapienza" University, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.
Azienda Ospedaliera Sant'Andrea · ITCTO Andrea Alesini · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the hypothesis that patients developing high-grade erythema of the breast skin during radiation treatment could be more likely to present increased levels of proinflammatory cytokines which may lead, in turn, to associated fatigue. Forty women with early stage breast cancer who received adjuvant radiotherapy were enrolled from 2007 to 2010. Fatigue symptoms, erythema, and cytokine levels (IL-1β, IL-2, IL6, IL-8, TNF-α, and MCP-1) were registered at baseline, during treatment, and after radiotherapy completion. Seven (17.5%) patients presented fatigue without associated depression/anxiety. Grade ≥2 erythema was observed in 5 of these 7 patients. IL-1β, IL-2, IL-6, and TNF-α were statistically increased 4 weeks after radiotherapy (P < 0.05). After the Heckman two-step analysis, a statistically significant influence of skin erythema on proinflammatory markers increase (P = 0.00001) was recorded; in the second step, these blood markers showed a significant impact on fatigue (P = 0.026). A seeming increase of fatigue, erythema, and proinflammatory markers was observed between the fourth and the fifth week of treatment followed by a decrease after RT. There were no significant effects of hormone therapy, breast volume, and anemia on fatigue. Our study seems to suggest that fatigue is related to high-grade breast skin erythema during radiotherapy through the increase of cytokines levels.

Indexed as

AdultAgedBreast NeoplasmsCytokinesErythemaFatigueFemaleHumansMiddle AgedRadiotherapy, AdjuvantCytokines

Identifiers

PMID24800238
PMCPMC3988916
OpenAlexW1974802697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.